Due to the fact that sublingual immunotherapy (SLIT) is a long lasting treatment, the adherence for SLIT is a pivotal issue in order to achieve an adequate improvement of patients with IgE mediated disorders.
Sublingual immunotherapy: adherence based on timing and monitoring control visits
Article first published online: 21 OCT 2009
© 2009 John Wiley & Sons A/S
Volume 65, Issue 5, pages 668–669, May 2010
How to Cite
Vita, D., Caminiti, L., Ruggeri, P. and Pajno, G. B. (2010), Sublingual immunotherapy: adherence based on timing and monitoring control visits. Allergy, 65: 668–669. doi: 10.1111/j.1398-9995.2009.02223.x
- Issue published online: 1 APR 2010
- Article first published online: 21 OCT 2009
- Accepted for publication 9 September 2009
- 3Recommendations for standardization of clinical trials with allergen specific immunotherapy for respiratory allergy. A statement of a World Allergy Organization (WAO) taskforce. Allergy 2007;62:317–324., , , , , et al.
- 5Quantitative assessment of the compliance with once-daily sublingual immunotherapy in children (EASY project: evaluation of a novel SLIT formulation during a year). Pediatr Allergy Immunol 2007;18:58–62., , , , , et al.